Business Description
Sartorius Stedim Biotech SA
ISIN : FR0013154002
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.4 | |||||
Debt-to-EBITDA | 4.8 | |||||
Interest Coverage | 3.68 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.02 | |||||
Beneish M-Score | -2.93 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | 9.9 | |||||
3-Year EPS without NRI Growth Rate | -9.9 | |||||
3-Year FCF Growth Rate | 1.9 | |||||
3-Year Book Growth Rate | 22.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 15.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 12.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -24.73 | |||||
12-1 Month Momentum % | -24.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 0.57 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 236.38 | |||||
Days Sales Outstanding | 44.45 | |||||
Days Payable | 85.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 61.8 | |||||
Shareholder Yield % | -6.27 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.44 | |||||
Operating Margin % | 16.95 | |||||
Net Margin % | 11.16 | |||||
FCF Margin % | 9.84 | |||||
ROE % | 12.22 | |||||
ROA % | 4.99 | |||||
ROIC % | 6.61 | |||||
ROC (Joel Greenblatt) % | 26.39 | |||||
ROCE % | 10.11 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 75.77 | |||||
Forward PE Ratio | 43.86 | |||||
PE Ratio without NRI | 75.77 | |||||
Shiller PE Ratio | 71.15 | |||||
Price-to-Owner-Earnings | 49.33 | |||||
PEG Ratio | 3.02 | |||||
PS Ratio | 8.45 | |||||
PB Ratio | 8.9 | |||||
Price-to-Free-Cash-Flow | 86.07 | |||||
Price-to-Operating-Cash-Flow | 31.43 | |||||
EV-to-EBIT | 53.69 | |||||
EV-to-Forward-EBIT | 40.77 | |||||
EV-to-EBITDA | 37.04 | |||||
EV-to-Forward-EBITDA | 26.25 | |||||
EV-to-Revenue | 10.23 | |||||
EV-to-Forward-Revenue | 9.42 | |||||
EV-to-FCF | 103.89 | |||||
Price-to-Projected-FCF | 4.49 | |||||
Price-to-DCF (Earnings Based) | 1.8 | |||||
Price-to-DCF (FCF Based) | 2.11 | |||||
Price-to-Median-PS-Value | 0.64 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.03 | |||||
Earnings Yield (Greenblatt) % | 1.87 | |||||
FCF Yield % | 1.1 | |||||
Forward Rate of Return (Yacktman) % | 21.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sartorius Stedim Biotech SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 52,486.872 | ||
EPS (TTM) (MXN) | 63.955 | ||
Beta | 0 | ||
Volatility % | 24.73 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0.519236 | ||
20-Day SMA (MXN) | 4374.26 | ||
12-1 Month Momentum % | -24.73 | ||
52-Week Range (MXN) | 4374.26 - 5811.46 | ||
Shares Outstanding (Mil) | 97.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sartorius Stedim Biotech SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sartorius Stedim Biotech SA Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Sartorius Stedim Biotech SA Frequently Asked Questions
What is Sartorius Stedim Biotech SA(MEX:DIM)'s stock price today?
When is next earnings date of Sartorius Stedim Biotech SA(MEX:DIM)?
Does Sartorius Stedim Biotech SA(MEX:DIM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |